Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study.
Thomas P, Castelnau O, Paillotin D, Léna H, Robinet G, Muir JF, Delaval P, Gouva S, Balmes P, Blanchon F, Perdu D, Poirier R, Pommier De Santi P, Penot-Ragon C, Kleisbauer JP. Thomas P, et al. Among authors: blanchon f. J Clin Oncol. 2001 Mar 1;19(5):1320-5. doi: 10.1200/JCO.2001.19.5.1320. J Clin Oncol. 2001. PMID: 11230474 Clinical Trial.
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.
Pérol M, Léna H, Thomas P, Robinet G, Fournel P, Coste E, Belleguic C, Le Caer H, Blanchon F, Vergnenègre A, Vernejoux JM, Schuller-Lebeau MP, Pham E. Pérol M, et al. Among authors: blanchon f. Ann Oncol. 2002 May;13(5):742-7. doi: 10.1093/annonc/mdf128. Ann Oncol. 2002. PMID: 12075743 Free article. Clinical Trial.
Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study.
Monnet I, Audigier-Valette C, Girard N, Vergnenègre A, Molinier O, Souquet PJ, Blanchon F, Bonnetain F, Taguieva-Pioger N, Lamour C, Wislez M. Monnet I, et al. Among authors: blanchon f. Lung Cancer. 2016 Aug;98:84-90. doi: 10.1016/j.lungcan.2016.05.016. Epub 2016 May 26. Lung Cancer. 2016. PMID: 27393512
[Treatment of non-small cell lung cancer (2003 update)].
Lavolé A, Blanchon F, Breton JL, Milleron B. Lavolé A, et al. Among authors: blanchon f. Rev Mal Respir. 2004 Feb;21(1):175-8. doi: 10.1016/s0761-8425(04)71255-3. Rev Mal Respir. 2004. PMID: 15260057 Review. French. No abstract available.
[Primary lung cancer in elderly subjects in France].
Piquet J, Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M, Breton JL, Coëtmeur D, Delclaux B, Braun D, Homasson JP, Mouysset F, Riou R, le Poulain-Doubliez M, Marsal L; CPHG. Piquet J, et al. Among authors: blanchon f. Rev Mal Respir. 2004 Nov;21(5 Pt 3):8S70-8. Rev Mal Respir. 2004. PMID: 15803540 French.
[Five year survival for lung cancer patients managed in general hospitals].
Grivaux M, Zureik M, Marsal L, Asselain B, Peureux M, Chavaillon JM, Prud'homme A, Carbonnelle M, Goarant E, Maury B, Bedossa A, Blanchon F. Grivaux M, et al. Among authors: blanchon f. Rev Mal Respir. 2009 Jan;26(1):37-44. doi: 10.1016/s0761-8425(09)70132-9. Rev Mal Respir. 2009. PMID: 19212288 French.
[Primary non-small-cell lung cancer: analysis of 419 T1 (<or=3 cm) tumors in the KBP-2000-CPHG study].
Collon T, Ba O, Grivaux M, Dore P, Azarian R, Orion B, Boyer J, Raffy O, Jourdain B, Beraud A, Paillot N, Jouveshomme S, Mordacque C, Zureik M, Marsal L, Piquet J, Blanchon F; CPHG. Collon T, et al. Among authors: blanchon f. Rev Pneumol Clin. 2004 Dec;60(6 Pt 1):333-43. doi: 10.1016/s0761-8417(04)72146-x. Rev Pneumol Clin. 2004. PMID: 15699906 French.
71 results